Viapar Capital Presents... LP DAY

​Viapar Capital invites Private Investors, Family Offices, UHNWI, and Strategic Investors to an exclusive first look at our next phase of fundraising, highlighting our focused Healthtech vertical, Healthtech Gateway India (HGI). We are raising capital to invest in SEIS/EIS approved UK health-tech startups and strategically launch them into India’s booming market, while also backing high-potential Indian startups ready to expand into the UK.

​🚨 Why Now?

• ​UK–India Free Trade Agreement (FTA): Recently signed agreement set to boost bilateral trade beyond £100 billion by reducing tariffs and unlocking new cross-border healthcare opportunities.

• ​Surging Healthcare Demand: India’s health-tech market is growing rapidly, driven by digital innovation, favourable demographics, and healthcare infrastructure expansion.

• ​Tax-Efficient Opportunities: SEIS/EIS incentives offer significant tax advantages, enhancing returns for early-stage UK health-tech investments.

​🚀 Empowering Health-Tech Startups to Go Global

• ​Deploying capital coupled with Viapar’s proven UK–India corridor strategy

• ​Accelerating market entry with tailored regulatory, commercial, and operational support

• ​Leveraging deep local networks to scale businesses across the UK, India, and globally

​🤝 Join us to explore:

• ​Fundraising & Co-investment Opportunities

• ​Cross-Border Market Entry Strategies

• ​SEIS/EIS Tax-Optimised Structures

• ​Healthtech Gateway India Initiative